Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
PDF] Multiple myeloma associated with IgA lambda gammopathy and multiple myeloma oncogene 1 in a Yorkshire terrier | Semantic Scholar
The changes of serum IgA, free kappa/lambda ratio, creatinine and free... | Download Scientific Diagram